Chemical industry – Page 62
-
BusinessTeva fined $520m for corruption
World’s largest generics manufacturer admits paying bribes in Russia, Ukraine and Mexico
-
-
-
BusinessDuPont found liable in third bellwether cancer case
US court orders firm to pay $2m in damages to man whose disease has been linked to contaminated water supply
-
-
BusinessMylan may lay off up to 3500 staff
The move forms part of the US generic firm’s restructuring efforts
-
-
BusinessLonza to buy capsule manufacturer in $5.5bn deal
Swiss pharma firm looks to strengthen its position as world’s biggest drug manufacturing subcontractor
-
BusinessUS pharma executives face bribery charges over opioid painkiller prescriptions
Insys Therapeutics chief executive and senior managers accused of running a conspiracy to bribe doctors across several states
-
BusinessBristol-Myers Squibb planning huge reorganisation in the US
Job losses likely as Hopewell, New Jersey site will close by 2020
-
FeatureLab automation
Automated tools can take the drudgery out of routine lab work, Anthony King reports
-
CareersCatching up with AstraZeneca's graduate programme
Three years on, Manisha Lalloo revisits the pharma giant’s training scheme
-
BusinessSyngenta subsidiary faces fine over pesticide exposure
US environment agency wants firm to pay $5 million after workers hospitalised after coming into contact with chlorpyrifos
-
BusinessPharmaceutical industry roundup of 2016
Controversial approvals and price clashes characterised 2016 in pharma
-
BusinessDeath sentence for head of Tianjin explosion firm
48 Ruihai Logistics staff and government officials also sentenced
-
BusinessWashington state sues Monsanto over PCBs
Attorney general wants to recoup damages and cleanup costs related to polychlorinated biphenyls
-
BusinessTrump names Dow Chief to head US manufacturing council
US president-elect appoints Andrew Liveris, despite lacking appropriate authority
-
OpinionHow to make Reach risk assessments more transparent
Chemical safety data is still hard to access because of the ECHA’s own rules
-
BusinessEndo drops opioid painkiller rights and cuts US sales force
375 staff to go as Endo says its established pain drugs ‘no longer require field promotion’
-
BusinessBoehringer Ingelheim sheds more jobs in the US
Over 240 staff to go as company refocuses on immuno-oncology